Shares of Suven Life Sciences zoomed 17% to Rs 204, extending its previous 7% gain, after the company said it received one product patent each in three countries.
The secured products patents are one each from South Korea (10-1386354), China (CN102639526) and Canada (CA 2737282) corresponding to the New Chemical Entities for the treatment of disorders associated with neurodegenerative diseases, the company said in a release adding that these patents are valid through 2029, 2029 and 2031, respectively.
The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and are useful for treating Alzheimer's disease, Attention deficient hyperactivity disorder, Huntington's disease, Parkinson and Schizophrenia.
The stock opened at Rs 177 and touched a high of Rs 206 so far. Over 7.5 million shares were traded on both the stock exchanges so far.
